ClinicalTrials.gg
Status unknownNCT03616847Updated May 24, 2019

Comparison of Different Tourniquet Release Times in Bunion Surgery

An interventional study of Standard care and Tourniquet release in Hallux Valgus and Hallux Rigidus, sponsored by Golden Jubilee National Hospital. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-05-24.

Sponsored by Golden Jubilee National Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Patients listed for hallux valgus/hallux rigidus correction surgery will be randomised to one of two treatment groups. Group 1 (standard care) will have the calf tourniquet released after wound closure. Group 2 will have the tourniquet removed five minutes before wound closure. Participants will have the volume of their operated foot measured pre-operatively and post-operatively at six weeks and three months.

Read the detailed description

Pneumatic tourniquets provide the benefits of better visualisation and decreased blood loss, but can also cause metabolic changes due to ischemia and compressive damage due to pressure. Surveys of foot and ankle surgeons demonstrates prevalent use of tourniquets in their clinical practice, with various patterns of use differing amongst the surgeons.

Bunion surgery is one of the most common surgical procedures in foot surgery. It involves correcting the hallux valgus deformity through a combination of various osteotomy, fusion, or soft tissue procedures. Swelling after any surgery is common, but particularly so after foot surgery as gravity causes fluid to collect in the foot. With regards to recovery after surgery, patients are advised to expect to be off work for between 6-8 weeks for a sedentary occupation, and between 12-14 weeks for heavy work. Although patients have low pain levels, the foot remains swollen for an average of 3-6 months after surgery. It is usually the swelling that prevents patients from getting in to normal footwear to be able to return to work sooner.

Bunion surgery is usually performed under a calf-tourniquet to create a bloodless surgical field and ensure less surgical bleeding, thereby reducing surgical time. However, use of tourniquets can lead to more swelling, increased post-operative pain and challenges in rehabilitation - all of which may affect recovery after bunion surgery. Prolonged duration of tourniquet use has been shown to cause post-operative wound healing complications, potentially attributable to local inflammation and tissue hypoxia. It is known from the studies for knee replacement surgery that tourniquet use can lead to decreased range of motion after surgery in early stage.

This study will be a randomised controlled trial with two study groups. The control group will have surgery with the tourniquet remaining in situ until the wound is closed. The intervention group will have the tourniquet released after surgery, but closure will be delayed by five minutes.

02

Conditions studied

  • Hallux Valgus
  • Hallux Rigidus

Keywords

  • Randomised controlled trial
  • Hallux valgus correction
  • Hallux rigidus correction
  • Tourniquet
  • Foot volume
03

In context

Hallux Valgus

157 studies on the registry are indexed under Hallux Valgus; 36 are open to participants now.

This study's planned enrollment of 80 is above the median of 58 across 119 interventional studies indexed under Hallux Valgus.

Browse Hallux Valgus studies →

Lead sponsor

Golden Jubilee National Hospital is the lead sponsor of 30 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients having hallux valgus or hallux rigidus
  • Able to give
  • Able to return for follow-up

Exclusion criteria

Exclusion Criteria:

  • Patients with symptomatic peripheral vascular disease
  • Patients with known peripheral oedema from any cause
  • Patients who will also require lesser toe correction as part of the procedure
  • Active smokers
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Standard care

    Participants will have hallux valgus/hallux rigidus surgery using a calf tourniquet which will remain inflated until the wound is closed.

    Other: Standard care

  • Experimental
    Tourniquet release

    Participants will have hallux valgus/hallux rigidus surgery using a calf tourniquet which will be removed. There will be a five minute delay before the wound is closed.

    Other: Tourniquet release

Interventions

  • OtherStandard care

    Hallux valgus/hallux rigidus surgery with the calf tourniquet remaining in situ until the wound is closed.

  • OtherTourniquet release

    Hallux valgus/hallux rigidus surgery with the calf tourniquet released five minutes before the wound is closed.

06

What researchers measure

Primary outcomes

  1. Foot volume

    The volume of the operated foot measured by water displacement (in millilitres).

    Time frame: 3 months post-operatively

Secondary outcomes

  1. MOxFQ score

    Manchester-Oxford Foot Questionnaire score (0-100, 100 being the most severe)

    Time frame: 3 months post-operatively

  2. Foot pain assessed using a dolometer

    Foot pain measured on a visual analogue scale (0-10, 0 being no pain \& 10 being worst pain imaginable).

    Time frame: 3 months post-operatively

  3. Return to work

    Time after surgery the participant returned to work (reported in weeks since surgery)

    Time frame: 3 months post-operatively

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — No data will be shared

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 24, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03616847
Lead sponsor
Golden Jubilee National Hospital
Responsible party
Sponsor
First posted
Aug 6, 2018
Start date
Aug 23, 2018
Primary completion
Aug 26, 2021 (estimated)
Completion
Nov 25, 2021 (estimated)
Last update
May 24, 2019

Study contacts

Alistair M Ewen, Ph. D.
Contact
alistair.ewen@gjnh.scot.nhs.uk
0141 951 5946
Kathryn Macpherson, B. Sc.
Contact
kathryn.macpherson@gjnh.scot.nhs.uk
0141 951 5121
Kalpesh Shah, M.D.
principal investigator · Gloden Jubilee National Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion